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Abstract
Introduction Our goal was to describe the epidemiology,
clinical profiles, outcomes, and factors that might predict
progression of critically ill patients to chronically critically ill
(CCI) patients, a still poorly characterized subgroup.
Methods We prospectively studied all patients admitted to a
university-affiliated hospital intensive care unit (ICU) between 1
July 2002 and 30 June 2005. On admission, we recorded
epidemiological data, the presence of organ failure (multiorgan
dysfunction syndrome (MODS)), underlying diseases (McCabe
score), acute respiratory distress syndrome (ARDS) and shock.
Daily, we recorded MODS, ARDS, shock, mechanical
ventilation use, lengths of ICU and hospital stay (LOS), and
outcome. CCI patients were defined as those having a
tracheotomy placed for continued ventilation. Clinical
complications and time to tracheal decannulation were
registered. Predictors of progression to CCI were identified by
logistic regression.
Results Ninety-five patients (12%) fulfilled the CCI definition
and, compared with the remaining 690 patients, these CCI
patients were sicker (APACHE II, 21 ± 7 versus 18 ± 9 for non-
CCI patients, p = 0.005); had more organ dysfunctions (SOFA
7 ± 3 versus 6 ± 4, p < 0.003); received more interventions
(TISS 32 ± 10 versus 26 ± 8, p  < 0.0001); and had less
underlying diseases and had undergone emergency surgery
more frequently (43 versus 24%, p = 0.001). ARDS and shock
were present in 84% and 83% of CCI patients, respectively,
versus 44% and 48% in the other patients (p < 0.0001 for
both). CCI patients had higher expected mortality (38% versus
32%,  p  = 0.003), but observed mortality was similar (32%
versus 35%, p = 0.59). Independent predictors of progression
to CCI were ARDS on admission, APACHE II and McCabe
scores (odds ratio (OR) 2.26, p < 0.001; OR 1.03, p < 0.01;
and OR 0.34, p < 0.0001, respectively). Lengths of mechanical
ventilation, ICU and hospital stay were 33 (24 to 50), 39 (29 to
55) and 55 (37 to 84) days, respectively. Tracheal
decannulation was achieved at 40 ± 19 days.
Conclusion CCI patients were a severely ill population, in which
ARDS, shock, and MODS were frequent on admission, and who
suffered recurrent complications during their stay. However,
their prognosis was equivalent to that of the other ICU patients.
ARDS, APACHE II and McCabe scores were independent
predictors of evolution to chronicity.
Introduction
A growing population of patients (5% to 10%) survive acute
critical illness only to become chronically critically ill (CCI),
with profound weakness and ongoing respiratory failure [1].
The most perceptible feature of this group is their prolonged
dependence on mechanical ventilation (up to 7% to 15% of
intensive care unit (ICU) patients) [2]; however, chronic critical
illness might be considered as a far more complex syndrome,
characterized by physiological, metabolic, immunological, neu-
roendocrine and neuromuscular disturbances [1]. Repeated
episodes of sepsis are the hallmark of the CCI, and possibly
contribute to lengthened ICU stay.
APACHE = Acute Physiologic and Chronic Health Evaluation; ARDS = acute respiratory distress syndrome; CCI = chronically critically ill; ICU = 
intensive care unit; LOS = length of stay; MODS = multiorgan dysfunction syndrome; SOFA = sequential organ failure assessment; TISS = thera-
peutic intervention scoring system; VAP = ventilator-associated pneumonia.Critical Care    Vol 10 No 3    Estenssoro et al.
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The CCI are expected to increase, since more patients with
complex diseases survive due to advances in resuscitation
techniques, mechanical ventilation protocols, metabolic con-
trol and treatment of sepsis [3-6]. The use of invasive proce-
dures and devices, and the presence of malnutrition and
immunosuppression are well-known risk factors for infection in
the ICU and are especially frequent in the CCI [7]. Despite
prolonged and resource-intensive care, these patients suffer
early mortality or slow recovery, with excessive functional
dependency. In addition, the cost of their care is seemingly
high, which has recently focused attention on their character-
istics and outcomes [8]. Since data about this group are
scarce, there is a plea to continuing research on them [9].
There is some controversy about who should be considered a
CCI patient. Some overlap with the definition of prolonged
mechanical ventilation (mechanical ventilation ≥21 days)
seems unavoidable [2]. Notwithstanding this, other investiga-
tors have proposed the placement of a tracheotomy as a
marker for chronic critical illness, given that it foresees the
need for long-lasting ventilatory support [8]. In addition, the
analysis of the events occurring during the whole length of ICU
stay – and not just the days spent on mechanical ventilation –
might yield a more comprehensive approach to the CCI, since
there are other non-ventilatory, severe conditions that might
also require prolonged ICU care (airway problems, parenteral
nutrition, complicated wound care or continuous
hemofiltration).
Our goal was to describe the epidemiological features, clinical
complications, infectious profiles, and the outcomes of this
recently defined, poorly characterized subgroup of ICU
patients. In addition, we sought for independent predictors of
evolution to chronic critical illness.
Materials and methods
Study design
This is a prospective cohort study carried out in a medical-sur-
gical ICU located in a university-affiliated hospital of 474 beds
in La Plata, Buenos Aires, Argentina. This study was approved
by the Institutional Review Board. Informed consent was
waived since no interventions on patients would be performed.
Patients
Patients admitted to the ICU between 1 July 2002 and 30
June 2005 that ultimately required a tracheotomy placed for
continued ventilation were considered CCI [9]. Patients with
tracheotomies performed for other conditions, such as maxilo-
facial trauma or laryngeal surgery, were excluded. Tracheoto-
mies are performed in our ICU based on an expectation of a
prolonged mechanical ventilation course. CCI patients usually
remain in the hospital until death or weaning, because health
systems in Argentina do not provide readily accessible long-
term acute care facilities for their transfer.
For the whole population, we prospectively recorded: age,
gender, main diagnosis, primary source of admission (emer-
gency room, hospital ward, other hospital), severity of illness
(Acute Physiologic and Chronic Health Evaluation (APACHE)
II score) [10] and predicted mortality on admission; intensity of
procedures and organ failures (therapeutic intervention scor-
ing system (TISS)24 hs and sequential organ failure assessment
(SOFA)24 hs scores) during the first day of admission [11,12];
type of admission (medical, emergency or elective surgery);
causes of initiation of mechanical ventilation (respiratory,
hemodynamic, neurological and postoperative) [13]; and pre-
existent illnesses (McCabe score) as non-fatal (score of 1),
ultimately fatal (score of 2) or rapidly fatal disease (score of 3)
[14].
Every day, we screened all patients for the presence of: acute
respiratory distress syndrome (ARDS; defined as an acute
onset respiratory failure, with an arterial oxygen partial pres-
sure/inspired oxygen concentration relationship (PaO2/FiO2)
≤200 and bilateral infiltrates on chest X-ray, in the absence of
a wedge pressure >18 mmHg or clinical heart failure) [15];
shock (defined as systolic blood pressure <90 mmHg or a
reduction of >40 mmHg from baseline despite adequate fluid
resuscitation, along with the presence of perfusion abnormali-
ties that might include oliguria, lactic acidosis, or acute altered
mental status) [16]; septic shock [16]; and causes for initiation
of mechanical ventilation [13], if newly started.
When a patient became tracheotomised, we prospectively
recorded the following complications daily and during the
entire length of ICU stay: organ dysfunctions; new episodes of
shock; respiratory events; neuromuscular events; neuropsy-
chological events; gastrointestinal and metabolic events; use
of hemodyalisis; and infectious complications. In addition, we
made a retrospective search for these complications in the
period that extended from the admission day to the day of tra-
cheotomy by reviewing clinical records and charts. Data pre-
sented correspond to the whole length of stay.
Organ dysfunctions
Organ dysfunctions (MODS) were defined as a SOFA score
>2 points in at least two organ systems (cardiovascular, respi-
ratory, neurological, hematological, renal hepatic).
Respiratory events
Respiratory events included: the development of ARDS; epi-
sodes of atelectasis, defined as pulmonary infiltrates that
resolve within 48 hours of bronchoscopy, recruitment maneu-
vers or chest physiotherapy, and no other etiology to account
for it [17]; a number of failed weaning attempts, defined as the
inability to sustain a spontaneous breathing trial of two hours
[18]; unplanned extubations [19]; extubation failures, defined
as reintubation within 48 hours; days to tracheotomy; decan-
nulation failures, defined as need for re-cannulation with a tra-
cheostomy tube after a decannulation attempt, due to airwayAvailable online http://ccforum.com/content/10/3/R89
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obstruction or to inability to swallow without aspiration of liq-
uid/food contents into the airway, evaluated either clinically or
by fiberoptic endoscopy [20]; days to successful decannula-
tion; and duration of mechanical ventilation (LOSMV), defined
as effective days on mechanical ventilation (days spent on T
tube during finally unsuccessful weaning attempts were not
considered as mechanical ventilation days).
Neuromuscular events
Neuromuscular events comprised the development of critical
illness polyneuropathy/myopathy. When sedative-analgesics
were withdrawn, patients were assessed for the presence of
muscular weakness. An electromyogram was then performed
to confirm the diagnosis. Infusion of neuromuscular blocking
agents lasting longer than 24 hours was also recorded.
Neuropsychological events
Neuropsychological events constituted the presence of intrac-
ranial hypertension, or psychomotor agitation, defined as the
presence of restlessness, anxiety, agitation or combativeness
(Ramsay sedation scale = 1) [21].
Gastrointestinal and metabolic events
Gastrointestinal and metabolic events recorded included clin-
ically evident upper gastrointestinal hemorrhage (altering
hemodynamics or requiring transfusion), diarrhea, ileus, days
Table 1
Epidemiological, clinical and outcome variables in CCI patients compared to the rest of ICU admissions
CCI Non-CCI P value
n 95 690
Age (years) 44 ± 16 41 ± 18 0.21
Gender (male) 50 (53) 356 (52) 0.76
APACHE II 21 ± 7 18 ± 9 0.005
APACHE II mortality risk 38% 32% 0.003
Mortality 30 (32) 240 (35) 0.59
SOFA 24 hours 7 ± 3 6 ± 4 0.003
McCabe score 1.2 ± 0.5 1.6 ± 0.8 <0.0001
TISS score 32 ± 10 26 ± 8 <0.0001
ARDS
At any point 80 (84) 304 (44) <0.0001
On admission 52 (55) 229 (33) 0.0001
In evolutionb 72 (76) 157 (23) <0.0001
Shock
At any point 79 (83) 331 (48) <0.0001
On admission 58 (61) 286 (42) <0.001
In evolutionb 68 (72) 180 (26) <0.0001
Cranial trauma 19 (20) 88 (13) 0.05
Admission type
Medical 47 (50) 360 (52) 0.70
Emergency surgery 40 (43) 164 (24) 0.001
Elective surgery 8 (9) 158 (23) 0.001
Mechanical ventilation 94 (100) 355 (51) <0.0001
LOMV(days)a 33 (24–50) 5 (2–9) <0.0001
LOSICU (days)a 39 (29–55) 4 (2–8) <0.0001
LOSHospital (days)a 55 (37–84) 17 (8–53) <0.0001
Data are shown as n (%), or mean ± standard deviation, unless specified. aMedian and 0.25 to 0.75 interquartile range. APACHE, Acute 
Physiologic and Chronic Health Evaluation; ARDS, acute respiratory distress syndrome; CCI, chronically critically ill; Evolutionb, developed during 
ICU stay; ICU, intensive care unit; LOMV, length of mechanical ventilation; LOSHospital, length of stay at the hospital; LOSICU, length of stay at the 
ICU; SOFA, sequential organ failure assessment; TISS, therapeutic intervention scoring system.Critical Care    Vol 10 No 3    Estenssoro et al.
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of enteral nutrition, interruptions and its causes: patient-
related (shock or intolerance) or nasogastric-tube related
(obstruction, malposition, accidental withdrawal) and days of
parenteral nutrition.
Infectious complications
Infectious complications were considered when fever or hypo-
thermia evolved, in which case cultures were taken and sites
of infection diagnosed as ventilator-associated pneumonia
(VAP), catheter-related infections, primary bacteremias, and
urinary tract infections. VAP was the presence of a new or per-
sistent radiographic infiltrate occurring > 48 hours after
mechanical ventilation onset [22], plus purulent tracheal
secretions, plus either a positive quantitative secretion culture
yielding ≥104 cfu/ml in bronchoalveolar lavage [22], or ≥103
cfu/ml in mini-bronchoalveolar lavage [23] or ≥106 cfu/ml in
tracheal aspirate [24]. Catheter-related infections constituted
≥15 cfu in a semi-quantitative, or ≥103 cfu in a quantitative, cul-
ture from a catheter tip, and/or exit-site infection plus isolation
of the same microorganism from blood drawn from a periph-
Table 2
Admission and clinical characteristics of CCI survivors and non-survivors
Survivors Non-survivors P value
n 64 31
Age (years) 40 ± 16 51 ± 12 0.0008
Gender (male) 35 (55) 15 (48) 0.56
APACHE II 20 ± 7 21 ± 6 0.51
APACHE II mortality risk (%) 37 42 0.33
SOFA 24 hours 7 ± 3 8 ± 3 0.28
McCabe score 1.2 ± 0.5 1.3 ± 0.6 0.38
TISS 32 ± 9 32 ± 19 0.81
Pre-admission
Emergency room 38 (59) 16 (51) 0.47
Hospital ward 12 (19) 5 (16) 0.75
Transfer from other hospital 26 (41) 6 (19) 0.04
LOS previous hospitals (days) 6 ± 8 6 ± 8 0.97
Cause of mechanical ventilation
Respiratory 19 (30) 9 (29) 0.95
Hemodynamic 23 (36) 9 (29) 0.50
Neurological 13 (20) 6 (19) 0.91
Postoperative 9 (14) 7 (23) 0.24
MODS 42 (68) 29(94) 0.01
ARDS
On admission 35 (55) 17 (55) 0.98
In evolutionb 48 (75) 24 (77) 0.79
Shock
On admission 39 (61) 19 (61) 0.97
In evolutionb 45 (70) 23 (77) 0.46
Number of shock episodes 59 55 0.05
LOSICU (days)a 38 (29–53) 44 (30–58) 0.34
LOSHospital (days)a 65 (42–83) 50 (32–62) 0.05
Data are shown as n (%), or mean ± standard deviation, unless specified. aMedian and 0.25 to 0.75 interquartile range. APACHE, Acute 
Physiologic and Chronic Health Evaluation; ARDS, acute respiratory distress syndrome; CCI, chronically critically ill; Evolutionb, developed during 
ICU stay; ICU, intensive care unit; LOMV, length of mechanical ventilation; LOSHospital, length of stay at the hospital; LOSICU, length of stay at the 
ICU; SOFA, sequential organ failure assessment; TISS, therapeutic intervention scoring system.Available online http://ccforum.com/content/10/3/R89
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eral vein and no other apparent source of infection [25]. Pri-
mary bacteremias were at least one positive blood culture
without another site simultaneously infected with the same
microorganism [26]. Urinary tract infections were pyuria (≥105
leucocytes/mm3) plus urine culture ≥105 cfu/ml [26].
Isolated microorganisms, absolute, relative number of infec-
tious episodes, frequency of polymicrobial infections, and
days to first episode and crude mortality for each type of infec-
tion were registered. Incidence densities (episodes per 1,000
days ICU stay or device use for mechanical ventilation, cathe-
ters, urinary catheters) were calculated and compared to
those of non-CCI patients.
After death or discharge, ICU and hospital stay (LOSICU and
LOSHosp) were recorded.
Outcome variables
The main outcome variable for the entire population was the
evolution to chronic critical illness. For CCI patients, it was
hospital mortality.
Do-not-resuscitate orders were not explicitly recorded, since
this is an infrequent practice in countries of Latin origin [27].
Statistical analysis
Results are expressed as percentages, mean ± standard devi-
ation for continuous parametric variables, and median and
interquartile range (25% to 75% IQ) for continuous, non-par-
ametric variables. Comparisons between groups were per-
formed by the use of Chi-square, t, and Mann-Whitney tests,
as appropriate. A p value of less than 0.05 was considered
significant. Variables that differed between CCI and non-CCI
patients on admission (p < 0.10) were tested for interaction
with multiple logistic regression analysis, looking for independ-
ent predictors of evolution to chronicity. Odds ratios (ORs)
and 95% confidence intervals were calculated. A p value <
0.05 was considered significant. Discrimination of the logistic
regression model was assessed using the area under the
receiver operator characteristic curve.
All statistical analyses were performed with statistical software
(Stata 8.0; Stata Corporation, College Station, TX, USA).
Results
Comparison of CCI versus the rest of the patients
During the study period, 785 patients were admitted to the
ICU; 95 patients (12%) were considered CCI. Only 21 (3%)
of the remaining 690 patients had a tracheotomy placed for
other reasons (13 for head and neck trauma/surgery, 8 for
otorhinolaryngological diseases). Characteristics of both
groups of patients are shown in Table 1. Of note, CCI patients
were significantly more acutely ill on admission, according to
prognostic, organ dysfunction and intervention scores, and to
the prior requirement for emergency surgery. Recurring epi-
sodes of ARDS and shock were the rule in CCI patients during
their ICU stay. Interestingly, underlying diseases were signifi-
cantly more common in the non-CCI patients. As expected,
CCI patients had a protracted course of disease, demon-
strated by a longer duration of mechanical ventilation and ICU
and hospital LOS. Despite this, the observed hospital mortality
of 32% for CCI patients was lower than expected, and similar
to non-CCI patients.
Of the variables that differed between CCI and non-CCI
patients, ARDS on admission (OR 2.26, p < 0.001), APACHE
II (OR 1.03 per point, p < 0.01) and McCabe score (OR 0.34,
p < 0.0001) independently predicted evolution to chronic crit-
ical illness. Discrimination of the model was fair (the area under
the receiver operator curve was 0.74).
Characterization of CCI patients and comparison 
between survivors and non-survivors
CCI patients showed high rates of hemodynamic, respiratory,
gastrointestinal, nutrition-related and neuropsychological
events (Tables 2 and 3). Perioperative shock on admission
(32% of shock cases), and septic shock developing during
ICU stay (95% of cases) were the most common causes of
hemodynamic dysfunction.
On admission, CCI survivors and non-survivors had similar
severity of illness, organ failures and high rates of ARDS and
shock (Table 2). At discharge/death, they also had similar
lengths of mechanical ventilation and stay at the ICU. The var-
iables that differed between survivors and non-survivors were
age and having been transferred from another hospital, and
the number of shock episodes showed significant differences
between them (Table 2). In addition, the non-survivors showed
an increased frequency of MODS (94% versus 68% in survi-
vors;  p  < 0.01), upper gastrointestinal hemorrhage (29%
versus11%, p = 0.03), ileus (25% versus 48%, p < 0.02), and
longer duration of parenteral nutrition (58 ± 34 versus 12 ± 7,
p < 0.02). Other variables, such as weaning attempts and suc-
cessful and failed decannulations, were, expectably, more fre-
quent in surviving patients.
A detailed description of events in the whole CCI population
is given in Table 3.
Infectious episodes were recurrent and showed an important
crude mortality (Table 4). Primary bacteremia (of unidentified
source) was the most frequent single infection type, with a rate
of 1.3 episodes per patient rate. Prevalent microorganisms
found were: Gram-negative bacilli in 63% of primary bactere-
mias (45% Enterobacteriaceae); Acinetobacter  and  Pseu-
domonas in 28 and 22% of VAPs; Candida in 70% of urinary-
tract infections; and Gram-negative bacilli in 45% of catheter-
related infections.Critical Care    Vol 10 No 3    Estenssoro et al.
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Discussion
The main contributions of this study refer to the characteriza-
tion of a growing subgroup of ICU patients, the CCI, in terms
of frequency, prognostic factors and outcome.
The CCI patients represented 12% of admissions, and were
similar to the remaining patients in age and gender. However,
they were more acutely ill from the start – previous comorbid
states were uncommon – and had higher predicted mortality
than non-CCI patients (38% versus 32%). Surprisingly, evolu-
tion to chronically critical illness did not lead to a worse prog-
nosis: mortality rate was 32% and 35% for CCI and non-CCI
patients, respectively. Most studies on CCI have been done in
post-ICU settings, so comparison is difficult [28-30]; however,
reported mortality rates lie between 29% and 51%. In two
studies enrolling ICU patients undergoing prolonged mechan-
ical ventilation, mortality rates have been as high as 71% and
43% [31,32], but these figures might have changed due to
recent advances produced in the critical care arena [3-6].
More recently, ICU mortalities of 25% [33] and 44% [34] have
been reported for patients undergoing mechanical ventilation
for more than 14 days, and in an international study of mechan-
ical ventilation, hospital mortality of tracheostomised patients
equaled that of non-tracheostomised patients (39% versus
40%) [35].
Interestingly, reported one to three year survival rates are good
[28-30], with an acceptable health-related quality of life [31].
These are encouraging results in the face of the elevated num-
bers of complications CCI patients do develop.
There are no available models to predict progression of ICU
patients to chronically critical illness [1]. Indeed, we identified
admission variables as ARDS, APACHE II and absence of sig-
nificant comorbidities as independent risk factors for evolution
to CCI.
Severity scores have been repeatedly identified as predictors
of prolonged mechanical ventilation [36,37]. This condition
and chronically critical illness might have common character-
istics, and so share some determinants. However, the pres-
ence of ARDS and the absence of underlying disease as
predictors of chronicity in the ICU are novel findings.
This last result requires further discussion. CCI patients were
more acutely ill, but had less underlying diseases than the non-
CCI. Mortality was equal for both. Perhaps, with less comor-
bidity, the CCI patients had a greater physiological reserve
that allowed them not to die. Instead, they developed a chronic
course of disease with plenty of complications.
It is difficult to ascertain whether complication rates were a
consequence of the prolonged exposure to the ICU milieu, or
of the complex pathophysiological features of chronic critical
illness [1,8,9]. In any case, event rates might need considera-
ble adjustment before comparing them to those of other ICU
populations [38].
Respiratory events
As expected [39], many unsuccessful weaning attempts (11 ±
12 per patient) occurred in this chronic, debilitated and multi-
infected population. Atelectasis (in 35% of patients), malnutri-
Table 3
Events, complications and outcomes in CCI patients
n 95
MODS 71 (76)
Hemodyalisis 8 (9)
Respiratory events
LOMV
a 33 (24–50)
Weaning attempts 11 ± 11
Atelectasis 33 (35)
Unplanned extubations 15 (17)
Day of tracheotomya 16 ± 6
Extubation failures 24 (26)
Decannulation failures 22 (23)
Successful decannulations 62 (66)
Days to successful decannulation 40 ± 19
Neuromuscular events
Axonal polyneuropathy 14 (15)
Myopathy 3 (3)
Infusion of neuromuscular relaxants 13 (14)
Neuropsychological events
Intracranial hypertension 26 (28)
Psychomotor agitation 15 (16)
GI and metabolic events
Upper GI hemorrhage 16 (17)
Diarrhea 44 (47)
Ileus 31 (33)
Enteral nutrition (days) 30 ± 21
Enteral nutrition (interruptions/patient) 4 ± 3
Interruptions related to patient problems 3 ± 2
Interruptions related to tube problems 2 ± 1
Parenteral nutrition (patients) 9 (14)
Parenteral nutrition (days) 32 ± 32
Data are shown as n (%), or mean ± standard deviation, unless 
specified. aMedian and 0.25 to 0.75 interquartile range. APACHE, 
Acute Physiologic and Chronic Health Evaluation; ARDS, acute 
respiratory distress syndrome; CCI, chronically critically ill; ICU, 
intensive care unit; LOMV, length of mechanical ventilation; LOSHospital, 
length of stay at the hospital; LOSICU, length of stay at the ICU; MODS, 
multiorgan dysfunction syndrome; SOFA, sequential organ failure 
assessment; TISS, therapeutic intervention scoring system. GI, 
gastrointestinal.Available online http://ccforum.com/content/10/3/R89
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tion and critical illness polyneuropathy/myopathy could cer-
tainly account for that.
Tracheotomy was performed at 16 ± 6 days, and was pre-
ceded by 26% of extubation failures, which have been linked
to increased mortality when caused by airway-unrelated
causes [40]. Tracheal decannulation was a late achievement,
performed 40 ± 19 days after tracheotomy (one week after
weaning). Previous failures were observed in 23% of patients.
This reflects other neuromuscular disturbances that can pro-
long ICU stay – ineffective cough and swallowing dysfunction.
Neuromuscular and neuropsychological events
Critical illness polyneuropathy/myopathy, another manifesta-
tion of the systemic response inflammatory syndrome [41],
occurred in 16% of patients. Axonal polyneuropathy was the
most frequent electromyogram diagnosis (13%), performed
approximately at day 25. More subtle forms might have gone
unrecognized. Psychomotor agitation occurred in only 16% of
patients, but this figure may not include minor alterations. The
relatively young age of our cohort might explain the relatively
low incidence of this complication.
Gastrointestinal and metabolic events
Stress-related mucosal damage and gastrointestinal hemor-
rhage occurs in up to 25% of critically ill patients [42]. Not-
withstanding the use of prophylactic therapy, clinically
significant bleeding occurred in 17% of patients, and was sig-
nificantly more frequent in non-survivors. It has been associ-
ated with increases in mortality and in ICU stay of as much as
11 days [43].
Interruptions of enteral nutrition were common, and mostly
related to shock. Ileus and diarrhea were frequent; however,
intolerance to enteral nutrition might act as a marker of severity
of illness [44].
Infectious events
Not unexpectedly, CCI patients have very high infection rates,
related to the exposure of multiple entry sites to a highly colo-
nized environment during long periods, intense antimicrobial
use, prolonged mechanical ventilation, parenteral nutrition,
cognitive impairment and compromised immune function.
Other particular characteristics of CCI patients explain the
high rate of some infections. Key risk factors for VAP are
present in this cohort: the use of mechanical ventilation during
long periods, which leads to an increasing incidence of VAP
until the 30th day, at which it plateaus [44]; and the great inci-
dence of ARDS (present in 83% of patients), which has been
found to precede VAP in 34% to 70% of patients [45].
Primary Gram-negative bacilli bacteremia was the most fre-
quent infection in CCI patients, and was more than double the
incidence in the rest of the patients. Catheter related infec-
tions displayed similar behavior. Recurrent episodes of infec-
tion and septic shock were frequent. Each type of infection
displayed a distinctive microorganism pattern, and polymicro-
bial isolations were common. These were late events, appear-
ing at a median of 17 (11 to 39) days, and might help to
identify appropriate empiric antimicrobial therapy, which has
been associated with better outcomes [46].
However, overall infection rates might be confounded by the
average LOS in the ICU [38], and also might just be an indica-
tor of greater severity of illness. Larger hospitals have higher
rates of device utilization, particularly ventilator use, which may
lead to increased overall infection rates in their ICUs. How-
ever, the use of cumulative incidences (normalizations to
events per 1,000 days of device use) might aid in comparisons
with other patient groups. Discharge policies, for example,
some ICUs can readily discharge CCI patients to step-down
facilities, may lower infection rates. Both variables (large bed
number, but lack of long-term acute care units) might have
affected the results in our study.
A strength of the current study is the prospective gathering of
data – only a small number of events were recorded retrospec-
tively but, even so, patients were in the ICU when tracheos-
tomy was performed, so the chance of having missed
retrospective data was small. Clinical complications were
assessed with standard definitions. In addition, the number of
patients is half that reported in a population-based cohort of
Table 4
Sites and number of infectious episodes in CCI patients, and comparison of incidence densities with the non-CCI patients
Patients n (%) Patients with ≥2 
episodes
Polimicrobial 
infections
Median (days) to 
first episode
Crude mortality Episodes/1,000 
days
Episodes/1,000 
days in non-CCI
PB 59 (72) 61% 27% 9 (7–17) 39% 18a 7a
VAP 57 (70) 61% 37% 8 (6–13) 38% 17b 12b
UTI 50 (61) 72% 23% 9 (7–16) 38% 6c 5c
CRI 16 (20) 56% 8% 17 (11–39) 50% 8d 3d
aNumber of episodes per 1,000 intensive care unit days. bNumber of episodes per 1,000 days of mechanical ventilation. cNumber of episodes per 
1,000 days of urinary catheter use. dNumber of episodes per 1,000 days of central intravenous catheter use. CCI, chronically critically ill; CRI, 
catheter-related infections; PB, primary bacteremia; VAP, ventilator-associated pneumonia; UTI, urinary tract infections.Critical Care    Vol 10 No 3    Estenssoro et al.
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patients with a long ICU stay recently published [33]. The per-
centage of tracheostomised patients is identical to that of the
European group of the International Mechanical Ventilation
Study Group [35]. The big number of events – reported for the
first time with such detail – gives a global picture of the prob-
lem of chronic patients in the ICU. This study also identifies
new factors associated with progression to chronicity.
The limitations of the present study are related to its observa-
tional design. Selection bias is possible, since physicians are
prone to tracheostomise patients that are expected to survive;
the 'protection' McCabe score seems to suggest (OR 0.34 in
the logistic regression model) points in this direction. Another
limitation refers to the generalizability of these results, since it
was carried out in a single ICU. Finally, practice patterns might
have changed during the three-year period this study took.
However, the main advances in critical care had already been
published [3-6] when the study started, so procedures and
therapeutics might not have changed further. Discharge poli-
cies were also maintained, since no new long-term acute care
units were opened in the area served by the hospital, nor was
the possibility of home care of the CCI accepted by most
health payers.
Conclusion
CCI patients are a distinct, acutely and severely ill population
in which ARDS, shock and organ failure are extremely frequent
from admission onwards, and who suffer recurrent respiratory,
infectious, gastrointestinal and neuropsychological complica-
tions during the course of their illness. The high frequency of
atelectasis, extubation failures, unsuccessful weaning
attempts, malnutrition and infections might explain their pro-
longed ICU stay. Even though hospital mortality is high, it is not
different from that of other admitted patients, and even lower
than expected. ARDS, APACHE II and the absence of signifi-
cant underlying diseases on admission independently pre-
dicted the evolution to chronic critical illness.
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